Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity

v3.22.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional paid in capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Balance (in shares) at Dec. 31, 2020   126,725,000      
Balance at Dec. 31, 2020 $ 407,750 $ 944,328 $ 39,383 $ (805) $ (575,156)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options and vesting of performance awards (in shares)   1,152,000      
Shares issued on exercise of stock options and vesting of performance awards 6,278 $ 9,518 (3,240)    
Exercise of warrants (in shares)   519,000      
Exercise of warrants 31 $ 726 (695)    
Shared-based compensation 15,574   15,574    
Unrealized loss on available-for-sale securities 13     13  
Net loss (97,389)       (97,389)
Balance (in shares) at Jun. 30, 2021   128,396,000      
Balance at Jun. 30, 2021 332,257 $ 954,572 51,022 (792) (672,545)
Balance (in shares) at Mar. 31, 2021   128,121,000      
Balance at Mar. 31, 2021 370,228 $ 952,673 43,889 (799) (625,535)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options and vesting of performance awards (in shares)   275,000      
Shares issued on exercise of stock options and vesting of performance awards 1,279 $ 1,899 (620)    
Shared-based compensation 7,753   7,753    
Unrealized loss on available-for-sale securities 7     7  
Net loss (47,010)       (47,010)
Balance (in shares) at Jun. 30, 2021   128,396,000      
Balance at Jun. 30, 2021 $ 332,257 $ 954,572 51,022 (792) (672,545)
Balance (in shares) at Dec. 31, 2021 141,600,000 141,600,000      
Balance at Dec. 31, 2021 $ 479,091 $ 1,177,051 59,014 (852) (756,122)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options and vesting of performance awards (in shares) 77,000 165,000      
Shares issued on exercise of stock options and vesting of performance awards $ 522 $ 1,928 (1,406)    
Issuance of common shares in conjunction with ESPP program (in shares)   127,000      
Issuance of common shares in conjunction with ESPP program 1,223 $ 1,905 (682)    
Shared-based compensation 17,078   17,078    
Unrealized loss on available-for-sale securities (1,001)     (1,001)  
Net loss $ (73,145)       (73,145)
Balance (in shares) at Jun. 30, 2022 141,892,000 141,892,000      
Balance at Jun. 30, 2022 $ 423,768 $ 1,180,884 74,004 (1,853) (829,267)
Balance (in shares) at Mar. 31, 2022   141,742,000      
Balance at Mar. 31, 2022 448,123 $ 1,178,807 64,686 (1,618) (793,752)
Increase (Decrease) in Stockholders' Equity          
Shares issued on exercise of stock options and vesting of performance awards (in shares)   23,000      
Shares issued on exercise of stock options and vesting of performance awards 117 $ 172 (55)    
Issuance of common shares in conjunction with ESPP program (in shares)   127,000      
Issuance of common shares in conjunction with ESPP program 1,223 $ 1,905 (682)    
Shared-based compensation 10,055   10,055    
Unrealized loss on available-for-sale securities (235)     (235) 0
Net loss $ (35,515)       (35,515)
Balance (in shares) at Jun. 30, 2022 141,892,000 141,892,000      
Balance at Jun. 30, 2022 $ 423,768 $ 1,180,884 $ 74,004 $ (1,853) $ (829,267)